Panbela Therapeutics, Inc. (PBLA)
USD 0.34
(7.19%)
USD 0.34
(7.19%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -232.42 Thousand USD | -470.4% |
| 2022 | -40.74 Thousand USD | -96.15% |
| 2021 | -20.77 Thousand USD | -40.38% |
| 2020 | -14.79 Thousand USD | 43.31% |
| 2019 | -26.1 Thousand USD | -1617.41% |
| 2018 | -1519.95 USD | 56.47% |
| 2017 | -3491.75 USD | -76.84% |
| 2016 | -1974.51 USD | 53.03% |
| 2015 | -4203.92 USD | -371.28% |
| 2014 | -892.03 USD | 49.51% |
| 2013 | -1766.84 USD | -185.71% |
| 2012 | 2061.50 USD | 278.85% |
| 2011 | -1152.61 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -2.28 USD | -8251.65% |
| 2024 Q2 | -1.47 USD | 35.53% |
| 2023 Q3 | -53.74 USD | 66.22% |
| 2023 FY | - USD | -470.4% |
| 2023 Q1 | -46.64 USD | 98.63% |
| 2023 Q2 | -159.09 USD | -241.1% |
| 2023 Q4 | -0.03 USD | 99.95% |
| 2022 Q2 | -36.24 Thousand USD | -453.88% |
| 2022 Q1 | -6543.64 USD | -3.52% |
| 2022 FY | - USD | -96.15% |
| 2022 Q4 | -3409.76 USD | 32.93% |
| 2022 Q3 | -5083.91 USD | 85.97% |
| 2021 FY | - USD | -40.38% |
| 2021 Q2 | -5198.06 USD | 5.12% |
| 2021 Q4 | -6321.06 USD | -63.35% |
| 2021 Q3 | -3869.56 USD | 25.56% |
| 2021 Q1 | -5478.39 USD | -4906.3% |
| 2020 Q2 | -74.69 USD | 77.04% |
| 2020 Q4 | -109.43 USD | 56.95% |
| 2020 Q3 | -254.22 USD | -240.37% |
| 2020 Q1 | -325.37 USD | -84.0% |
| 2020 FY | - USD | 43.31% |
| 2019 Q4 | -176.83 USD | 35.55% |
| 2019 Q3 | -274.36 USD | 48.96% |
| 2019 Q2 | -537.51 USD | -43.68% |
| 2019 Q1 | -374.11 USD | -89.75% |
| 2019 FY | - USD | -1617.41% |
| 2018 Q1 | -535.76 USD | 23.46% |
| 2018 FY | - USD | 56.47% |
| 2018 Q4 | -197.16 USD | 10.31% |
| 2018 Q3 | -219.82 USD | 66.31% |
| 2018 Q2 | -652.57 USD | -21.8% |
| 2017 Q4 | -699.94 USD | -75.59% |
| 2017 Q1 | -2076.38 USD | -149.07% |
| 2017 Q2 | -463.45 USD | 77.68% |
| 2017 Q3 | -398.63 USD | 13.99% |
| 2017 FY | - USD | -76.84% |
| 2016 Q4 | -833.64 USD | -106.13% |
| 2016 FY | - USD | 53.03% |
| 2016 Q2 | -389.64 USD | -17.84% |
| 2016 Q3 | -404.42 USD | -3.79% |
| 2016 Q1 | -330.66 USD | -38.43% |
| 2015 Q2 | -751.02 USD | -2.6% |
| 2015 FY | - USD | -371.28% |
| 2015 Q4 | -238.86 USD | 65.93% |
| 2015 Q3 | -701.15 USD | 6.64% |
| 2015 Q1 | -732.02 USD | 91.0% |
| 2014 Q3 | -797.55 USD | -66.97% |
| 2014 FY | - USD | 49.51% |
| 2014 Q2 | -477.67 USD | 48.15% |
| 2014 Q1 | -921.29 USD | -449.3% |
| 2014 Q4 | -8133.33 USD | -919.79% |
| 2013 Q3 | -485.12 USD | -19.28% |
| 2013 Q2 | -406.69 USD | 38.28% |
| 2013 FY | - USD | -185.71% |
| 2013 Q4 | -167.72 USD | 65.43% |
| 2013 Q1 | -658.97 USD | -168.41% |
| 2012 FY | - USD | 278.85% |
| 2012 Q3 | 613.39 USD | -20.16% |
| 2012 Q4 | 963.31 USD | 57.05% |
| 2012 Q1 | -283.42 USD | 0.0% |
| 2012 Q2 | 768.23 USD | 371.06% |
| 2011 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AbCellera Biologics Inc. | -0.51 USD | -45574321.569% |
| Alkermes plc | 2.14 USD | 10861293.925% |
| Agenus Inc. | -13.75 USD | -1690296.727% |
| Aptorum Group Limited | -0.62 USD | -37488537.097% |
| Ardelyx, Inc. | -0.30 USD | -77476416.667% |
| Dyadic International, Inc. | -0.24 USD | -96845545.833% |
| Eton Pharmaceuticals, Inc. | -0.04 USD | -636793187.671% |
| Lantern Pharma Inc. | -1.47 USD | -15811434.014% |
| Inhibikase Therapeutics, Inc. | -3.57 USD | -6510531.653% |
| Novavax, Inc. | -5.41 USD | -4296194.824% |
| Janux Therapeutics, Inc. | -1.32 USD | -17608199.242% |
| Pyxis Oncology, Inc. | -1.85 USD | -12563659.459% |
| TransCode Therapeutics, Inc. | -103.61 USD | -224231.194% |
| Ocuphire Pharma, Inc. | -0.46 USD | -50528063.043% |
| Outlook Therapeutics, Inc. | -4.72 USD | -4924254.873% |
| Madrigal Pharmaceuticals, Inc. | -19.99 USD | -1162629.115% |
| Reviva Pharmaceuticals Holdings, Inc. | -1.25 USD | -18594264.0% |
| SELLAS Life Sciences Group, Inc. | -1.34 USD | -17345388.806% |
| Syros Pharmaceuticals, Inc. | -5.81 USD | -4000408.606% |
| Barinthus Biotherapeutics plc | -1.91 USD | -12168986.387% |
| Windtree Therapeutics, Inc. | -92.23 USD | -251910.788% |
| Xeris Biopharma Holdings, Inc. | -0.45 USD | -51650911.111% |
| Clearside Biomedical, Inc. | -0.53 USD | -43854532.075% |
| C4 Therapeutics, Inc. | -2.67 USD | -8705126.592% |
| Alnylam Pharmaceuticals, Inc. | -3.52 USD | -6603012.216% |
| AlloVir, Inc. | -1.83 USD | -12700968.306% |
| Arrowhead Pharmaceuticals, Inc. | -1.91 USD | -12168986.387% |
| VYNE Therapeutics Inc. | -2.77 USD | -8390858.484% |
| Bicycle Therapeutics plc | -5.08 USD | -4575284.843% |
| BioXcel Therapeutics, Inc. | -6.15 USD | -3779242.276% |
| ChromaDex Corporation | -0.07 USD | -352700279.363% |
| Chimerix, Inc. | -0.93 USD | -24992324.731% |
| Corbus Pharmaceuticals Holdings, Inc. | -10.31 USD | -2254308.826% |
| Caribou Biosciences, Inc. | -1.38 USD | -16842621.014% |
| CRISPR Therapeutics AG | -1.94 USD | -11980804.639% |
| Precision BioSciences, Inc. | -15.96 USD | -1456225.501% |
| Fate Therapeutics, Inc. | -1.64 USD | -14172433.537% |
| Fortress Biotech, Inc. | -8.47 USD | -2744050.531% |
| Fortress Biotech, Inc. | -8.47 USD | -2744050.531% |
| HOOKIPA Pharma Inc. | -8.63 USD | -2693174.044% |
| ImmuCell Corporation | -0.75 USD | -30990506.667% |
| IDEAYA Biosciences, Inc. | -1.96 USD | -11858550.51% |
| Immix Biopharma, Inc. | -0.89 USD | -26115579.775% |
| Incyte Corporation | 2.67 USD | 8705326.592% |
| Innoviva, Inc. | 2.92 USD | 7960016.096% |
| IO Biotech, Inc. | -1.98 USD | -11738766.162% |
| Jaguar Health, Inc. | -107.42 USD | -216274.558% |
| Keros Therapeutics, Inc. | -5.20 USD | -4469699.038% |
| Ligand Pharmaceuticals Incorporated | 3.02 USD | 7696442.715% |
| ContextLogic Inc. | -13.36 USD | -1739642.141% |
| MiMedx Group, Inc. | 0.48 USD | 48422922.917% |
| MEI Pharma, Inc. | 2.67 USD | 8705326.592% |
| NextCure, Inc. | -2.25 USD | -10330102.222% |
| Onconetix, Inc. | -2.19 USD | -10613121.461% |
| Oncternal Therapeutics, Inc. | -13.43 USD | -1730574.237% |
| Opthea Limited | -0.35 USD | -66408342.857% |
| Psyence Biomedical Ltd. | -7.85 USD | -2960785.987% |
| Vaxcyte, Inc. | -4.14 USD | -5614140.338% |
| PDS Biotechnology Corporation | -1.39 USD | -16721450.36% |
| Precigen, Inc. | -0.39 USD | -59597220.513% |
| Pharming Group N.V. | -0.16 USD | -145268368.75% |
| Phathom Pharmaceuticals, Inc. | -3.93 USD | -5914137.913% |
| Pieris Pharmaceuticals, Inc. | -21.80 USD | -1066090.596% |
| PureTech Health plc | -2.38 USD | -9765847.479% |
| Rigel Pharmaceuticals, Inc. | -1.44 USD | -16140840.972% |
| Avidity Biosciences, Inc. | -2.91 USD | -7987169.759% |
| Reviva Pharmaceuticals Holdings, Inc. | -1.25 USD | -18594264.0% |
| Sangamo Therapeutics, Inc. | -1.48 USD | -15704599.324% |
| Sol-Gel Technologies Ltd. | -1.01 USD | -23012726.733% |
| Acelyrin, Inc. | -5.43 USD | -4280370.534% |
| Salarius Pharmaceuticals, Inc. | -0.00 USD | -6116567005.263% |
| Summit Therapeutics Inc. | -0.99 USD | -23477632.323% |
| Sensei Biotherapeutics, Inc. | -1.22 USD | -19051502.459% |
| Senti Biosciences, Inc. | -16.01 USD | -1451677.327% |
| Stoke Therapeutics, Inc. | -2.38 USD | -9765847.479% |
| Elevation Oncology, Inc. | -1.34 USD | -17345388.806% |
| Alaunos Therapeutics, Inc. | -21.97 USD | -1057840.601% |
| Telomir Pharmaceuticals, Inc. Common Stock | -0.44 USD | -52824797.727% |
| Entrada Therapeutics, Inc. | -0.20 USD | -116214675.0% |
| VistaGen Therapeutics, Inc. | -1.52 USD | -15291317.763% |
| Kintara Therapeutics, Inc. | -3.23 USD | -7195861.3% |
| Wave Life Sciences Ltd. | -0.54 USD | -43042409.259% |
| Seer, Inc. | -1.35 USD | -17216903.704% |
| Verrica Pharmaceuticals Inc. | -1.48 USD | -15704599.324% |
| Aadi Bioscience, Inc. | -2.44 USD | -9525701.23% |
| ESSA Pharma Inc. | -0.60 USD | -38738158.333% |
| GlycoMimetics, Inc. | -0.58 USD | -40073960.345% |
| GT Biopharma, Inc. | -5.64 USD | -4120991.312% |
| Inhibrx Biosciences, Inc. | -5.12 USD | -4539539.648% |
| Akebia Therapeutics, Inc. | -0.28 USD | -83010453.571% |
| Catalyst Pharmaceuticals, Inc. | 0.67 USD | 34691077.612% |
| Longboard Pharmaceuticals, Inc. | -2.39 USD | -9724985.774% |
| Orchestra BioMed Holdings, Inc. | -1.48 USD | -15704599.324% |
| Alzamend Neuro, Inc. | -14.72 USD | -1578905.095% |
| Sorrento Therapeutics, Inc. | -1.37 USD | -16965560.584% |
| TRACON Pharmaceuticals, Inc. | -2.20 USD | -10564879.545% |
| Viracta Therapeutics, Inc. | -1.32 USD | -17608199.242% |
| Rocket Pharmaceuticals, Inc. | -2.92 USD | -7959816.096% |
| Aptose Biosciences Inc. | -7.58 USD | -3066252.902% |
| ZyVersa Therapeutics, Inc. | -1089.67 USD | -21230.27% |
| Soligenix, Inc. | -12.66 USD | -1835836.414% |
| Century Therapeutics, Inc. | -2.30 USD | -10105532.609% |
| Kura Oncology, Inc. | -2.08 USD | -11174397.596% |
| TScan Therapeutics, Inc. | -1.36 USD | -17090308.088% |
| Intensity Therapeutics, Inc. | -1.38 USD | -16842621.014% |
| Ocean Biomedical, Inc. | -0.03 USD | -883762447.529% |
| CytomX Therapeutics, Inc. | -0.01 USD | -3018565484.416% |
| Autolus Therapeutics plc | -1.20 USD | -19369029.167% |
| Mineralys Therapeutics, Inc. | -1.99 USD | -11679776.884% |
| EyePoint Pharmaceuticals, Inc. | -1.82 USD | -12770754.396% |
| Eterna Therapeutics Inc. | -4.08 USD | -5696702.696% |
| Adaptive Biotechnologies Corporation | -1.56 USD | -14899230.128% |
| GRI Bio, Inc. | -28.25 USD | -822659.469% |
| Xenetic Biosciences, Inc. | -2.71 USD | -8576636.162% |
| Tenaya Therapeutics, Inc. | -1.68 USD | -13834992.262% |
| IGM Biosciences, Inc. | -4.71 USD | -4934709.979% |
| INmune Bio, Inc. | -1.67 USD | -13917837.126% |
| Heron Therapeutics, Inc. | -0.80 USD | -29053593.75% |
| SAB Biotherapeutics, Inc. | -7.64 USD | -3042171.597% |
| Pasithea Therapeutics Corp. | -12.65 USD | -1837287.747% |
| Entero Therapeutics, Inc. | -47.88 USD | -485341.834% |
| Milestone Pharmaceuticals Inc. | -1.39 USD | -16721450.36% |
| X4 Pharmaceuticals, Inc. | -0.57 USD | -40777014.035% |
| Atara Biotherapeutics, Inc. | -65.18 USD | -356496.425% |
| Coherus BioSciences, Inc. | -2.53 USD | -9186838.735% |
| Verastem, Inc. | -3.96 USD | -5869333.081% |
| Abeona Therapeutics Inc. | -2.53 USD | -9186838.735% |
| Pliant Therapeutics, Inc. | -2.75 USD | -8451883.636% |
| Tonix Pharmaceuticals Holding Corp. | -219.09 USD | -105988.617% |
| Histogen Inc. | -3.46 USD | -6717517.052% |
| Aprea Therapeutics, Inc. | -3.95 USD | -5884192.405% |
| Surrozen, Inc. | -21.33 USD | -1089583.779% |
| Organovo Holdings, Inc. | -1.60 USD | -14526746.875% |
| Lixte Biotechnology Holdings, Inc. | -2.66 USD | -8737853.008% |
| Ovid Therapeutics Inc. | -0.74 USD | -31409298.649% |
| CASI Pharmaceuticals, Inc. | -2.02 USD | -11506313.366% |
| Cadrenal Therapeutics, Inc. Common Stock | -0.62 USD | -37488537.097% |
| Centessa Pharmaceuticals plc | -1.57 USD | -14804329.936% |
| Hepion Pharmaceuticals, Inc. | -12.32 USD | -1886503.49% |
| Arcturus Therapeutics Holdings Inc. | -1.12 USD | -20752538.393% |
| BioRestorative Therapies, Inc. | -2.47 USD | -9410003.239% |
| Apollomics, Inc. | -2.32 USD | -10018415.086% |
| Amarin Corporation plc | -0.15 USD | -154952933.333% |
| Mesoblast Limited | -0.89 USD | -26115579.775% |
| Turnstone Biologics Corp. | -4.77 USD | -4872636.897% |
| Kymera Therapeutics, Inc. | -2.52 USD | -9223294.841% |
| Synaptogenix, Inc. | -29.56 USD | -786197.53% |
| Tiziana Life Sciences Ltd | -0.16 USD | -145268368.75% |
| Aurinia Pharmaceuticals Inc. | -0.54 USD | -43042409.259% |
| BriaCell Therapeutics Corp. | -0.29 USD | -80148020.69% |
| Monopar Therapeutics Inc. | -0.58 USD | -40073960.345% |
| Exelixis, Inc. | 0.65 USD | 35758492.308% |
| Better Therapeutics, Inc. | -1.69 USD | -13753127.811% |
| Nurix Therapeutics, Inc. | -2.65 USD | -8770826.415% |
| Apellis Pharmaceuticals, Inc. | -4.45 USD | -5223035.955% |
| NLS Pharmaceutics AG | -0.32 USD | -72634134.375% |
| Dermata Therapeutics, Inc. | -40.18 USD | -578370.757% |
| Aridis Pharmaceuticals, Inc. | -1.64 USD | -14172433.537% |
| Gritstone bio, Inc. | -1.20 USD | -19369029.167% |
| Jasper Therapeutics, Inc. | -6.18 USD | -3760895.955% |
| TNF Pharmaceuticals, Inc. | -5.33 USD | -4360679.55% |
| Avid Bioservices, Inc. | -2.23 USD | -10422749.776% |
| Insmed Incorporated | -5.34 USD | -4352513.296% |
| Virpax Pharmaceuticals, Inc. | -12.97 USD | -1791955.127% |
| MediWound Ltd. | -0.75 USD | -30990506.667% |
| OmniAb, Inc. | -0.51 USD | -45574321.569% |
| Alector, Inc. | -1.56 USD | -14899230.128% |
| Seres Therapeutics, Inc. | -0.89 USD | -26115579.775% |
| Checkpoint Therapeutics, Inc. | -2.77 USD | -8390858.484% |
| Zai Lab Limited | -3.46 USD | -6717517.052% |
| Revance Therapeutics, Inc. | -3.83 USD | -6068556.658% |
| Aura Biosciences, Inc. | -1.93 USD | -12042881.865% |
| Lyell Immunopharma, Inc. | -0.93 USD | -24992324.731% |
| Immunic, Inc. | -2.11 USD | -11015518.483% |
| Tarsus Pharmaceuticals, Inc. | -4.62 USD | -5030842.641% |
| Veracyte, Inc. | -1.02 USD | -22787110.784% |
| InMed Pharmaceuticals Inc. | -1.01 USD | -23012726.733% |
| FibroGen, Inc. | -2.92 USD | -7959816.096% |
| SeaStar Medical Holding Corporation | -30.29 USD | -767247.474% |
| Adial Pharmaceuticals, Inc. | -5.44 USD | -4272502.022% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.14 USD | -1281209.537% |
| Jazz Pharmaceuticals plc | 6.95 USD | 3344410.072% |
| Cyclacel Pharmaceuticals, Inc. | -26.75 USD | -868795.514% |
| Amylyx Pharmaceuticals, Inc. | 0.73 USD | 31839764.384% |
| TG Therapeutics, Inc. | 0.09 USD | 260279551.288% |
| Galecto, Inc. | -36.08 USD | -644106.07% |
| Calithera Biosciences, Inc. | -7.94 USD | -2927224.307% |
| Fortrea Holdings Inc. | -0.04 USD | -606865565.796% |
| KalVista Pharmaceuticals, Inc. | -3.44 USD | -6756572.965% |
| Aptevo Therapeutics Inc. | -62.62 USD | -371074.625% |
| XBiotech Inc. | -0.81 USD | -28694906.173% |
| Jasper Therapeutics, Inc. | -6.18 USD | -3760895.955% |
| Lyra Therapeutics, Inc. | -1.26 USD | -18446689.683% |
| Foghorn Therapeutics Inc. | -2.34 USD | -9932786.752% |
| Y-mAbs Therapeutics, Inc. | -0.49 USD | -47434502.041% |
| Theravance Biopharma, Inc. | -1.00 USD | -23242855.0% |
| Ultragenyx Pharmaceutical Inc. | -8.25 USD | -2817227.879% |
| Metagenomi, Inc. Common Stock | -1.82 USD | -12770754.396% |
| Vaxxinity, Inc. | -0.45 USD | -51650911.111% |
| BioCryst Pharmaceuticals, Inc. | -1.18 USD | -19697319.492% |
| Gain Therapeutics, Inc. | -1.71 USD | -13592271.345% |
| Cartesian Therapeutics, Inc. | -42.49 USD | -546921.77% |
| NexImmune, Inc. | -30.82 USD | -754051.687% |
| Creative Medical Technology Holdings, Inc. | -3.76 USD | -6181536.968% |
| Marker Therapeutics, Inc. | -1.93 USD | -12042881.865% |
| Regeneron Pharmaceuticals, Inc. | 37.05 USD | 627440.216% |
| Chemomab Therapeutics Ltd. | -2.06 USD | -11282887.864% |
| Scopus BioPharma Inc. | -0.55 USD | -42259818.182% |
| RAPT Therapeutics, Inc. | -3.05 USD | -7620540.984% |
| Ainos, Inc. | -3.36 USD | -6917446.131% |
| Pluri Inc. | -3.99 USD | -5825202.005% |
| Prothena Corporation plc | -2.76 USD | -8421260.507% |
| Adaptimmune Therapeutics plc | -0.57 USD | -40777014.035% |
| Celularity Inc. | -11.02 USD | -2109061.071% |
| Rallybio Corporation | -1.84 USD | -12631940.761% |
| Cue Biopharma, Inc. | -1.11 USD | -20939499.099% |
| MeiraGTx Holdings plc | -1.49 USD | -15599198.658% |
| Omeros Corporation | -1.88 USD | -12363173.936% |
| Humacyte, Inc. | -1.07 USD | -21722287.85% |
| Immunocore Holdings plc | -1.13 USD | -20568886.726% |
| Cocrystal Pharma, Inc. | -1.86 USD | -12496112.366% |
| Cidara Therapeutics, Inc. | -5.25 USD | -4427129.524% |
| Blueprint Medicines Corporation | -8.37 USD | -2776836.081% |
| CalciMedica, Inc. | -7.65 USD | -3038194.771% |
| Cabaletta Bio, Inc. | -1.65 USD | -14086539.394% |
| Marinus Pharmaceuticals, Inc. | -2.63 USD | -8837525.475% |
| Scholar Rock Holding Corporation | -1.99 USD | -11679776.884% |
| Sana Biotechnology, Inc. | -1.46 USD | -15919732.192% |
| Pulmatrix, Inc. | -3.87 USD | -6005831.525% |
| Elicio Therapeutics, Inc. | -6.96 USD | -3339405.029% |
| Vigil Neuroscience, Inc. | -2.13 USD | -10912085.446% |
| Intellia Therapeutics, Inc. | -5.42 USD | -4288268.081% |
| Adlai Nortye Ltd. American Depositary Shares | -7.26 USD | -3201408.953% |
| Cytokinetics, Incorporated | -5.45 USD | -4264662.385% |
| Eloxx Pharmaceuticals, Inc. | -16.65 USD | -1395873.273% |
| Nutriband Inc. | -0.69 USD | -33685342.029% |
| Protara Therapeutics, Inc. | -3.57 USD | -6510531.653% |
| Vor Biopharma Inc. | -1.75 USD | -13281588.571% |
| Roivant Sciences Ltd. | 5.55 USD | 4188019.82% |
| Evogene Ltd. | -5.23 USD | -4444059.656% |
| ProKidney Corp. | -0.57 USD | -40777014.035% |
| Applied Therapeutics, Inc. | -1.42 USD | -16368178.169% |
| Hoth Therapeutics, Inc. | -2.30 USD | -10105532.609% |
| BridgeBio Pharma, Inc. | -3.95 USD | -5884192.405% |
| CorMedix Inc. | -0.91 USD | -25541608.791% |
| BioLineRx Ltd. | -0.94 USD | -24726447.872% |
| Tango Therapeutics, Inc. | -1.08 USD | -21521154.63% |
| Galectin Therapeutics Inc. | -0.74 USD | -31409298.649% |
| Atai Life Sciences N.V. | -0.25 USD | -92971720.0% |
| Renovaro Biosciences Inc. | -0.84 USD | -27670084.524% |
| Aerovate Therapeutics, Inc. | -2.87 USD | -8098490.592% |
| Zentalis Pharmaceuticals, Inc. | -4.47 USD | -5199666.219% |
| Sagimet Biosciences Inc. | -2.66 USD | -8737853.008% |
| MediciNova, Inc. | -0.17 USD | -136723164.706% |
| Praxis Precision Medicines, Inc. | -18.69 USD | -1243503.799% |
| Cardio Diagnostics Holdings, Inc. | -0.66 USD | -35216498.485% |
| GeoVax Labs, Inc. | -10.22 USD | -2274161.742% |
| Axsome Therapeutics, Inc. | -5.27 USD | -4410327.894% |
| Biomea Fusion, Inc. | -3.44 USD | -6756572.965% |
| PTC Therapeutics, Inc. | -8.37 USD | -2776836.081% |
| Mereo BioPharma Group plc | -0.04 USD | -519976521.924% |
| Cullinan Oncology, Inc. | -3.69 USD | -6298803.794% |
| Syndax Pharmaceuticals, Inc. | -2.98 USD | -7799549.329% |
| Absci Corporation | -1.20 USD | -19369029.167% |
| NRx Pharmaceuticals, Inc. | -3.98 USD | -5839838.442% |
| 4D Molecular Therapeutics, Inc. | -2.58 USD | -9008797.287% |
| Dyne Therapeutics, Inc. | -3.95 USD | -5884192.405% |
| Kiniksa Pharmaceuticals, Ltd. | 0.20 USD | 116214875.0% |
| Ventyx Biosciences, Inc. | -3.30 USD | -7043219.697% |
| Allakos Inc. | -2.14 USD | -10861093.925% |
| Imunon, Inc. | -2.16 USD | -10760527.315% |
| Fulcrum Therapeutics, Inc. | -1.59 USD | -14618110.692% |
| Corcept Therapeutics Incorporated | 1.02 USD | 22787310.784% |
| BioAtla, Inc. | -2.58 USD | -9008797.287% |
| NLS Pharmaceutics AG | -0.32 USD | -72634134.375% |
| Bio-Path Holdings, Inc. | -33.64 USD | -690832.075% |
| Allogene Therapeutics, Inc. | -2.09 USD | -11120931.1% |
| Larimar Therapeutics, Inc. | -0.84 USD | -27670084.524% |
| XOMA Corporation | -4.04 USD | -5753106.683% |
| Kezar Life Sciences, Inc. | -1.40 USD | -16602010.714% |
| Cara Therapeutics, Inc. | -2.19 USD | -10613121.461% |
| aTyr Pharma, Inc. | -0.94 USD | -24726447.872% |
| Aligos Therapeutics, Inc. | -3.52 USD | -6603012.216% |
| Akero Therapeutics, Inc. | -2.89 USD | -8042444.983% |
| Viridian Therapeutics, Inc. | -5.31 USD | -4377104.331% |
| Eliem Therapeutics, Inc. | -1.30 USD | -17879096.154% |
| EyeGate Pharmaceuticals, Inc. | -2.54 USD | -9150669.685% |
| Akari Therapeutics, Plc | -2.04 USD | -11393505.392% |
| Tevogen Bio Holdings Inc. | -0.00 USD | -58107387400.0% |
| Halozyme Therapeutics, Inc. | 2.13 USD | 10912285.446% |
| Lexaria Bioscience Corp. | -1.01 USD | -23012726.733% |
| UroGen Pharma Ltd. | -3.55 USD | -6547211.268% |
| Sutro Biopharma, Inc. | -1.78 USD | -13057739.888% |
| ZIVO Bioscience, Inc. | -4.60 USD | -5052716.304% |
| Orgenesis Inc. | -1.91 USD | -12168986.387% |
| Entera Bio Ltd. | -0.31 USD | -74977174.194% |
| GH Research PLC | -0.68 USD | -34180716.176% |
| Lisata Therapeutics, Inc. | -2.58 USD | -9008797.287% |
| Reneo Pharmaceuticals, Inc. | -25.23 USD | -921142.767% |
| Xencor, Inc. | -2.08 USD | -11174397.596% |
| 60 Degrees Pharmaceuticals, Inc. | -0.95 USD | -24466168.421% |
| Replimune Group, Inc. | -3.24 USD | -7173651.543% |
| Coeptis Therapeutics Holdings, Inc. | -0.83 USD | -28003460.241% |
| Vanda Pharmaceuticals Inc. | 0.04 USD | 531875500.458% |
| Lexaria Bioscience Corp. | -1.01 USD | -23012726.733% |
| Portage Biotech Inc. | -3.70 USD | -6281779.73% |
| Cardio Diagnostics Holdings, Inc. | -0.66 USD | -35216498.485% |
| Olema Pharmaceuticals, Inc. | -2.14 USD | -10861093.925% |
| OncoCyte Corporation | -3.75 USD | -6198021.333% |
| Qualigen Therapeutics, Inc. | -2.46 USD | -9448255.691% |
| Processa Pharmaceuticals, Inc. | -8.48 USD | -2740814.505% |
| Purple Biotech Ltd. | -0.09 USD | -258830133.853% |
| CollPlant Biotechnologies Ltd. | -0.62 USD | -37488537.097% |
| scPharmaceuticals Inc. | -1.42 USD | -16368178.169% |
| ProMIS Neurosciences, Inc. | -1.42 USD | -16368178.169% |
| HilleVax, Inc. | -3.04 USD | -7645608.882% |
| NeuroSense Therapeutics Ltd. | -0.83 USD | -28003460.241% |
| Tharimmune, Inc. | -107.08 USD | -216961.589% |
| Genprex, Inc. | -22.58 USD | -1029260.275% |
| Neumora Therapeutics, Inc. Common Stock | -1.49 USD | -15599198.658% |
| Atossa Therapeutics, Inc. | -0.24 USD | -96845545.833% |
| XTL Biopharmaceuticals Ltd. | -0.00 USD | -7043319596.97% |
| Virios Therapeutics, Inc. | -0.28 USD | -83010453.571% |
| OKYO Pharma Limited | -0.00 USD | -38738258233.333% |
| Savara Inc. | -0.33 USD | -70433096.97% |
| Curis, Inc. | -8.96 USD | -2593979.799% |
| Daré Bioscience, Inc. | -4.15 USD | -5600612.048% |
| Carmell Therapeutics Corporation | -1.46 USD | -15919732.192% |
| Titan Pharmaceuticals, Inc. | -7.41 USD | -3136601.08% |
| Achieve Life Sciences, Inc. | -1.50 USD | -15495203.333% |
| BeiGene, Ltd. | -8.45 USD | -2750545.562% |
| Kiromic BioPharma, Inc. | -21.41 USD | -1085512.097% |
| Revolution Medicines, Inc. Warrant | -3.86 USD | -6021390.933% |
| Protagonist Therapeutics, Inc. | -1.39 USD | -16721450.36% |
| Erasca, Inc. | -0.83 USD | -28003460.241% |
| bluebird bio, Inc. | -1.93 USD | -12042881.865% |
| Protagenic Therapeutics, Inc. | -1.15 USD | -20211165.217% |
| BioMarin Pharmaceutical Inc. | 0.89 USD | 26115779.775% |
| DBV Technologies S.A. | -0.76 USD | -30582735.526% |
| Protagenic Therapeutics, Inc. | -1.15 USD | -20211165.217% |
| Moderna, Inc. | -12.34 USD | -1883445.786% |
| Vincerx Pharma, Inc. | -1.89 USD | -12297759.788% |
| Fresh Tracks Therapeutics, Inc. | -0.96 USD | -24211311.458% |
| Molecular Templates, Inc. | -1.80 USD | -12912652.778% |
| Acrivon Therapeutics, Inc. Common Stock | -2.74 USD | -8482730.292% |
| Travere Therapeutics, Inc. | -1.50 USD | -15495203.333% |
| Monte Rosa Therapeutics, Inc. | -2.63 USD | -8837525.475% |
| Spruce Biosciences, Inc. | -1.24 USD | -18744218.548% |
| Celldex Therapeutics, Inc. | -2.92 USD | -7959816.096% |
| Cogent Biosciences, Inc. | -2.42 USD | -9604426.86% |
| MacroGenics, Inc. | -0.15 USD | -154952933.333% |
| RenovoRx, Inc. | -0.99 USD | -23477632.323% |
| Adicet Bio, Inc. | -3.31 USD | -7021940.785% |
| Prime Medicine, Inc. | -2.18 USD | -10661805.963% |
| Aditxt, Inc. | -4326.64 USD | -5272.057% |
| Adagene Inc. | -0.44 USD | -52824797.727% |
| Estrella Immunopharma, Inc. | -0.21 USD | -110680638.095% |
| Quantum-Si incorporated | -0.68 USD | -34180716.176% |
| Maravai LifeSciences Holdings, Inc. | -0.90 USD | -25825405.556% |
| Acurx Pharmaceuticals, Inc. | -1.15 USD | -20211165.217% |
| Voyager Therapeutics, Inc. | 3.08 USD | 7546513.961% |
| SciSparc Ltd. | -14.43 USD | -1610638.392% |
| Vericel Corporation | -0.07 USD | -347428225.859% |
| Revelation Biosciences, Inc. | -0.53 USD | -43854532.075% |
| Minerva Neurosciences, Inc. | -4.61 USD | -5041755.748% |
| Generation Bio Co. | -1.96 USD | -11858550.51% |
| Astria Therapeutics, Inc. | -2.42 USD | -9604426.86% |
| Black Diamond Therapeutics, Inc. | -1.88 USD | -12363173.936% |
| Arcutis Biotherapeutics, Inc. | -3.78 USD | -6148829.894% |
| Invivyd, Inc. | -1.81 USD | -12841311.602% |
| Relay Therapeutics, Inc. | -2.79 USD | -8330708.244% |
| Quoin Pharmaceuticals, Ltd. | -9.64 USD | -2410994.917% |
| Spero Therapeutics, Inc. | 0.43 USD | 54053483.721% |
| Artelo Biosciences, Inc. | -3.49 USD | -6659772.493% |
| 2seventy bio, Inc. | -4.42 USD | -5258487.104% |
| ADMA Biologics, Inc. | -0.13 USD | -178791861.538% |
| Clene Inc. | -9.43 USD | -2464688.441% |
| Capricor Therapeutics, Inc. | -0.83 USD | -28003460.241% |
| Boundless Bio, Inc. Common Stock | -2.22 USD | -10469699.55% |
| GeoVax Labs, Inc. | -10.22 USD | -2274161.742% |
| Recursion Pharmaceuticals, Inc. | -1.58 USD | -14710631.013% |
| Citius Pharmaceuticals, Inc. | -0.22 USD | -105649695.455% |
| Contineum Therapeutics, Inc. Class A Common Stock | 1.36 USD | 17090508.088% |
| Relmada Therapeutics, Inc. | -3.28 USD | -7086166.768% |
| Finch Therapeutics Group, Inc. | -46.59 USD | -498782.915% |
| ALX Oncology Holdings Inc. | -3.74 USD | -6214593.85% |
| Vir Biotechnology, Inc. | -4.59 USD | -5063724.619% |
| Evaxion Biotech A/S | -8.11 USD | -2865862.392% |
| Ocular Therapeutix, Inc. | -1.09 USD | -21323711.927% |
| Verve Therapeutics, Inc. | -3.12 USD | -7449565.064% |
| Trevena, Inc. | -54.51 USD | -426298.0% |
| Surrozen, Inc. | -21.33 USD | -1089583.779% |
| Tyra Biosciences, Inc. | -1.62 USD | -14347403.086% |
| Cingulate Inc. | -311.99 USD | -74399.038% |
| Galmed Pharmaceuticals Ltd. | -30.05 USD | -773376.04% |
| Unity Biotechnology, Inc. | -2.70 USD | -8608401.852% |
| Tenax Therapeutics, Inc. | -31.09 USD | -747502.284% |
| Terns Pharmaceuticals, Inc. | -1.27 USD | -18301439.37% |
| ACADIA Pharmaceuticals Inc. | -0.37 USD | -62818697.297% |
| Connect Biopharma Holdings Limited | -1.08 USD | -21521154.63% |
| Clearmind Medicine Inc. | -59.18 USD | -392650.169% |
| Kronos Bio, Inc. | -1.95 USD | -11919364.103% |
| Bolt Biotherapeutics, Inc. | -1.83 USD | -12700968.306% |
| CERo Therapeutics Holdings, Inc. | -0.39 USD | -59597220.513% |
| Viking Therapeutics, Inc. | -0.91 USD | -25541608.791% |
| Statera Biopharma, Inc. | -4.97 USD | -4676550.905% |
| ImmunityBio, Inc. | -1.15 USD | -20211165.217% |
| Korro Bio, Inc. | -53.08 USD | -437785.362% |
| Kineta, Inc. | -1.28 USD | -18158458.594% |
| BioVie Inc. | -7.30 USD | -3183866.438% |
| Codexis, Inc. | -1.12 USD | -20752538.393% |
| Celularity Inc. | -11.02 USD | -2109061.071% |
| Crinetics Pharmaceuticals, Inc. | -3.69 USD | -6298803.794% |
| Celcuity Inc. | -2.69 USD | -8640403.717% |
| Virax Biolabs Group Limited | -3.36 USD | -6917446.131% |
| Cibus, Inc. | -25.95 USD | -895582.274% |
| Eledon Pharmaceuticals, Inc. | -0.00 USD | -14526846775.0% |
| eFFECTOR Therapeutics, Inc. | -16.37 USD | -1419750.641% |
| IN8bio, Inc. | -1.00 USD | -23242855.0% |
| Kodiak Sciences Inc. | -4.97 USD | -4676550.905% |
| Annexon, Inc. | -1.77 USD | -13131512.994% |
| Adverum Biotechnologies, Inc. | -11.62 USD | -2000154.303% |
| Assembly Biosciences, Inc. | -13.38 USD | -1737041.629% |
| Avalo Therapeutics, Inc. | -113.58 USD | -204539.505% |
| Ionis Pharmaceuticals, Inc. | -2.56 USD | -9079179.297% |
| Eyenovia, Inc. | -0.66 USD | -35216498.485% |
| Puma Biotechnology, Inc. | 0.46 USD | 50528263.043% |
| Conduit Pharmaceuticals Inc. | -0.09 USD | -257112234.071% |
| Xilio Therapeutics, Inc. | -2.78 USD | -8360675.18% |
| Arcellx, Inc. | -1.47 USD | -15811434.014% |
| Cardiff Oncology, Inc. | -0.93 USD | -24992324.731% |
| Enanta Pharmaceuticals, Inc. | -6.38 USD | -3642996.395% |
| Regulus Therapeutics Inc. | -1.58 USD | -14710631.013% |
| Moolec Science SA | -1.50 USD | -15495203.333% |
| Acumen Pharmaceuticals, Inc. | -1.08 USD | -21521154.63% |
| Geron Corporation | -0.32 USD | -72634134.375% |
| LAVA Therapeutics N.V. | -1.57 USD | -14804329.936% |
| Royalty Pharma plc | 3.41 USD | 6816215.836% |
| Atea Pharmaceuticals, Inc. | -1.63 USD | -14259381.595% |
| Greenwich LifeSciences, Inc. | -0.69 USD | -33685342.029% |
| TFF Pharmaceuticals, Inc. | -11.85 USD | -1961330.802% |
| Mersana Therapeutics, Inc. | -1.48 USD | -15704599.324% |
| Humacyte, Inc. | -1.07 USD | -21722287.85% |
| Structure Therapeutics Inc. | -2.44 USD | -9525701.23% |
| 89bio, Inc. | -2.00 USD | -11621377.5% |
| PMV Pharmaceuticals, Inc. | -1.44 USD | -16140840.972% |
| Avenue Therapeutics, Inc. | -73.60 USD | -315701.019% |
| Genelux Corporation | -1.16 USD | -20036930.172% |
| Trevi Therapeutics, Inc. | -0.29 USD | -80148020.69% |
| Lexicon Pharmaceuticals, Inc. | -0.80 USD | -29053593.75% |
| Notable Labs, Ltd. | -5.03 USD | -4620765.805% |
| Liquidia Corporation | -1.21 USD | -19208953.719% |
| Mustang Bio, Inc. | -6.00 USD | -3873725.833% |
| Immunovant, Inc. | -1.88 USD | -12363173.936% |
| Quantum-Si incorporated | -0.68 USD | -34180716.176% |
| Arbutus Biopharma Corporation | -0.44 USD | -52824797.727% |
| DiaMedica Therapeutics Inc. | -0.60 USD | -38738158.333% |
| Vera Therapeutics, Inc. | -2.25 USD | -10330102.222% |
| Acasti Pharma Inc. | -1.35 USD | -17216903.704% |
| MiNK Therapeutics, Inc. | -0.65 USD | -35758292.308% |
| Pasithea Therapeutics Corp. | -12.65 USD | -1837287.747% |
| Xenon Pharmaceuticals Inc. | -2.73 USD | -8513802.93% |
| Elevai Labs, Inc. Common Stock | -0.40 USD | -58107287.5% |
| NeuroBo Pharmaceuticals, Inc. | -2.46 USD | -9448255.691% |
| Tempest Therapeutics, Inc. | -1.91 USD | -12168986.387% |
| Soleno Therapeutics, Inc. | -2.36 USD | -9848609.746% |
| PepGen Inc. | -3.30 USD | -7043219.697% |
| Moleculin Biotech, Inc. | -15.07 USD | -1542232.78% |
| United Therapeutics Corporation | 21.04 USD | 1104803.184% |
| Nuvectis Pharma, Inc. | -1.43 USD | -16253714.685% |
| Solid Biosciences Inc. | -4.83 USD | -4812106.004% |
| BriaCell Therapeutics Corp. | -0.29 USD | -80148020.69% |
| Immuneering Corporation | -1.88 USD | -12363173.936% |
| Lixte Biotechnology Holdings, Inc. | -2.66 USD | -8737853.008% |
| Silo Pharma, Inc. | -1.20 USD | -19369029.167% |
| Belite Bio, Inc | -1.19 USD | -19531794.958% |
| XOMA Corporation | -4.04 USD | -5753106.683% |
| ARS Pharmaceuticals, Inc. | -0.57 USD | -40777014.035% |
| Bionomics Limited | -1.02 USD | -22787110.784% |
| Apogee Therapeutics, Inc. | -0.00 USD | -6836163135.294% |
| Alpha Tau Medical Ltd. | -0.42 USD | -55340269.048% |
| uniQure N.V. | -6.47 USD | -3592319.629% |
| Cassava Sciences, Inc. | -2.32 USD | -10018415.086% |
| Estrella Immunopharma, Inc. | -0.21 USD | -110680638.095% |
| Poseida Therapeutics, Inc. | -1.37 USD | -16965560.584% |
| Forte Biosciences, Inc. | -24.92 USD | -932602.849% |
| Anebulo Pharmaceuticals, Inc. | -0.32 USD | -72634134.375% |
| Enlivex Therapeutics Ltd. | -1.56 USD | -14899230.128% |
| Conduit Pharmaceuticals Inc. | -0.09 USD | -257112234.071% |
| SeaStar Medical Holding Corporation | -30.29 USD | -767247.474% |
| FibroBiologics, Inc. Common Stock | -0.59 USD | -39394738.983% |
| Altimmune, Inc. | -1.66 USD | -14001680.12% |
| Amicus Therapeutics, Inc. | -0.51 USD | -45574321.569% |
| Alpha Tau Medical Ltd. | -0.42 USD | -55340269.048% |
| Compugen Ltd. | -0.21 USD | -110680638.095% |
| Peak Bio, Inc. | - USD | Infinity% |
| Zevra Therapeutics, Inc. | -1.30 USD | -17879096.154% |
| Benitec Biopharma Inc. | -5.36 USD | -4336272.201% |
| Spyre Therapeutics, Inc. | -49.12 USD | -473087.195% |
| NKGen Biotech, Inc. Common Stock | -5.38 USD | -4320151.859% |
| Zura Bio Limited | -2.09 USD | -11120931.1% |
| PolyPid Ltd. | -16.99 USD | -1367937.375% |
| Aileron Therapeutics, Inc. | -3.42 USD | -6796085.673% |
| NKGen Biotech, Inc. Warrants | -5.38 USD | -4320151.859% |
| Instil Bio, Inc. | -24.00 USD | -968356.458% |
| argenx SE | -5.16 USD | -4504348.643% |
| Immunome, Inc. | -5.38 USD | -4320151.859% |
| Compass Therapeutics, Inc. | -0.33 USD | -70433096.97% |
| Verona Pharma plc | -0.54 USD | -43042409.259% |
| enGene Holdings Inc. Warrants | -4.51 USD | -5153548.559% |
| Shattuck Labs, Inc. | -2.05 USD | -11337926.829% |
| CervoMed Inc. | -0.82 USD | -28344967.073% |
| LENZ Therapeutics, Inc. | -15.30 USD | -1519047.386% |
| Plus Therapeutics, Inc. | -4.24 USD | -5481729.009% |
| Dianthus Therapeutics, Inc. | -8.45 USD | -2750545.562% |
| Moolec Science SA | -1.50 USD | -15495203.333% |
| Enveric Biosciences, Inc. | -8.09 USD | -2872947.59% |
| Inovio Pharmaceuticals, Inc. | -6.09 USD | -3816477.176% |
| AnaptysBio, Inc. | -6.08 USD | -3822754.441% |
| Design Therapeutics, Inc. | -1.19 USD | -19531794.958% |
| Leap Therapeutics, Inc. | -3.98 USD | -5839838.442% |
| NeurAxis, Inc. | -4.03 USD | -5767382.63% |
| Seelos Therapeutics, Inc. | -7.73 USD | -3006750.582% |
| Lumos Pharma, Inc. | -4.18 USD | -5560415.55% |
| Achilles Therapeutics plc | -1.74 USD | -13357920.115% |
| enGene Holdings Inc. Common Stock | -4.51 USD | -5153548.559% |
| 180 Life Sciences Corp. | -52.60 USD | -441781.274% |
| Opiant Pharmaceuticals, Inc. | 0.68 USD | 34180916.176% |
| CERo Therapeutics Holdings, Inc. | -0.39 USD | -59597220.513% |
| Nutriband Inc. | -0.69 USD | -33685342.029% |
| ORIC Pharmaceuticals, Inc. | -1.96 USD | -11858550.51% |
| CG Oncology, Inc. Common stock | -15.65 USD | -1485072.843% |
| Fractyl Health, Inc. Common Stock | -1.98 USD | -11738766.162% |
| Rani Therapeutics Holdings, Inc. | -1.33 USD | -17475806.015% |
| MoonLake Immunotherapeutics | -0.73 USD | -31839564.384% |
| Palisade Bio, Inc. | -27.01 USD | -860431.47% |
| Tourmaline Bio, Inc. | -8.87 USD | -2620300.789% |
| Beam Therapeutics Inc. | -1.72 USD | -13513245.93% |
| Neurogene Inc. | -2.83 USD | -8212958.304% |
| Mirum Pharmaceuticals, Inc. | -4.00 USD | -5810638.75% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -2.38 USD | -9765847.479% |
| Sesen Bio, Inc. | -1.99 USD | -11679776.884% |
| Enliven Therapeutics, Inc. | -2.01 USD | -11563559.204% |
| Kiora Pharmaceuticals, Inc. | -24.25 USD | -958372.371% |
| Iovance Biotherapeutics, Inc. | -1.89 USD | -12297759.788% |
| Taysha Gene Therapies, Inc. | -0.96 USD | -24211311.458% |
| Athira Pharma, Inc. | -3.10 USD | -7497627.419% |
| Vaccinex, Inc. | -43.68 USD | -532018.933% |
| HCW Biologics Inc. | -0.70 USD | -33204121.429% |
| XOMA Corporation | -4.04 USD | -5753106.683% |
| Nektar Therapeutics | -1.45 USD | -16029524.138% |
| Arvinas, Inc. | -6.62 USD | -3510920.393% |
| Tevogen Bio Holdings Inc. | -0.00 USD | -58107387400.0% |
| Merus N.V. | -3.00 USD | -7747551.667% |
| Omega Therapeutics, Inc. | -1.80 USD | -12912652.778% |
| Quince Therapeutics, Inc. | -0.84 USD | -27670084.524% |
| Rezolute, Inc. | -1.33 USD | -17475806.015% |
| Clene Inc. | -9.43 USD | -2464688.441% |
| Indaptus Therapeutics, Inc. | -1.84 USD | -12631940.761% |
| BeyondSpring Inc. | -0.54 USD | -43042409.259% |
| Synlogic, Inc. | -8.81 USD | -2638146.879% |
| Allarity Therapeutics, Inc. | -0.01 USD | -2256597472.816% |
| Phio Pharmaceuticals Corp. | -46.87 USD | -495802.603% |
| Peak Bio, Inc. | - USD | Infinity% |
| Werewolf Therapeutics, Inc. | -1.05 USD | -22136047.619% |
| Krystal Biotech, Inc. | 0.40 USD | 58107487.5% |
| Karyopharm Therapeutics Inc. | -1.25 USD | -18594264.0% |
| SpringWorks Therapeutics, Inc. | -5.15 USD | -4513095.146% |
| Lipella Pharmaceuticals Inc. | -0.77 USD | -30185555.844% |
| MannKind Corporation | -0.04 USD | -519976521.924% |
| Ikena Oncology, Inc. | -1.63 USD | -14259381.595% |
| Cyclerion Therapeutics, Inc. | -8.99 USD | -2585323.248% |
| Gyre Therapeutics, Inc. | -1.41 USD | -16484265.248% |
| Gossamer Bio, Inc. | -1.18 USD | -19697319.492% |
| CohBar, Inc. | -4.13 USD | -5627734.14% |
| Cognition Therapeutics, Inc. | -0.86 USD | -27026591.86% |
| NRx Pharmaceuticals, Inc. | -3.98 USD | -5839838.442% |
| Legend Biotech Corporation | -2.94 USD | -7905667.007% |
| Mural Oncology plc | -12.43 USD | -1869807.884% |
| Biora Therapeutics, Inc. | -7.87 USD | -2953261.499% |
| PaxMedica, Inc. Common Stock | -11.00 USD | -2112895.909% |
| Disc Medicine, Inc. | -3.43 USD | -6776271.72% |
| Champions Oncology, Inc. | -0.54 USD | -43042409.259% |
| REGENXBIO Inc. | -6.02 USD | -3860855.98% |
| Ensysce Biosciences, Inc. | -4.69 USD | -4955753.945% |
| Anavex Life Sciences Corp. | -0.60 USD | -38738158.333% |
| Cellectar Biosciences, Inc. | -3.11 USD | -7473518.971% |
| Edgewise Therapeutics, Inc. | -1.57 USD | -14804329.936% |
| Vaxart, Inc. | -0.57 USD | -40777014.035% |
| PharmaCyte Biotech, Inc. | -1.80 USD | -12912652.778% |
| Aldeyra Therapeutics, Inc. | -0.64 USD | -36317017.188% |
| Cellectis S.A. | -1.77 USD | -13131512.994% |
| Longeveron Inc. | -10.22 USD | -2274161.742% |
| Repare Therapeutics Inc. | -2.23 USD | -10422749.776% |
| Sarepta Therapeutics, Inc. | -5.80 USD | -4007306.034% |
| Inozyme Pharma, Inc. | -1.37 USD | -16965560.584% |
| Revolution Medicines, Inc. | -3.86 USD | -6021390.933% |
| Nymox Pharmaceutical Corporation | -0.07 USD | -316230580.272% |
| Third Harmonic Bio, Inc. | -0.78 USD | -29798560.256% |
| ArriVent BioPharma, Inc. Common Stock | -2.17 USD | -10710939.171% |
| AN2 Therapeutics, Inc. | -2.74 USD | -8482730.292% |
| Anixa Biosciences, Inc. | -0.32 USD | -72634134.375% |
| Vertex Pharmaceuticals Incorporated | 14.05 USD | 1654402.847% |
| Denali Therapeutics Inc. | -1.06 USD | -21927216.038% |
| Revelation Biosciences, Inc. | -0.53 USD | -43854532.075% |
| Veru Inc. | -1.10 USD | -21129859.091% |
| Corvus Pharmaceuticals, Inc. | -0.56 USD | -41505176.786% |
| Cingulate Inc. | -311.99 USD | -74399.038% |
| Passage Bio, Inc. | -1.86 USD | -12496112.366% |
| Context Therapeutics Inc. | -1.50 USD | -15495203.333% |
| Exicure, Inc. | -2.11 USD | -11015518.483% |
| Day One Biopharmaceuticals, Inc. | -2.37 USD | -9807054.008% |
| Oramed Pharmaceuticals Inc. | -0.97 USD | -23961709.278% |
| Scinai Immunotherapeutics Ltd. | -16.62 USD | -1398393.081% |
| Rhythm Pharmaceuticals, Inc. | -3.20 USD | -7263323.438% |
| Nuvalent, Inc. | -2.17 USD | -10710939.171% |
| ABVC BioPharma, Inc. | -2.43 USD | -9564902.058% |
| Carisma Therapeutics, Inc. | -2.59 USD | -8974013.9% |
| Unicycive Therapeutics, Inc. | -1.28 USD | -18158458.594% |
| OmniAb, Inc. | -0.51 USD | -45574321.569% |
| Anew Medical, Inc. | 0.14 USD | 166021207.143% |
| Fennec Pharmaceuticals Inc. | -0.60 USD | -38738158.333% |
| Lipocine Inc. | -3.14 USD | -7402114.968% |
| Lexeo Therapeutics, Inc. Common Stock | -2.49 USD | -9334420.08% |
| Nautilus Biotechnology, Inc. | -0.51 USD | -45574321.569% |
| SAB Biotherapeutics, Inc. | -7.64 USD | -3042171.597% |
| G1 Therapeutics, Inc. | -0.93 USD | -24992324.731% |
| Bellerophon Therapeutics, Inc. | -2.08 USD | -11174397.596% |
| Sage Therapeutics, Inc. | -9.05 USD | -2568182.32% |
| Ocugen, Inc. | -0.26 USD | -89395880.769% |
| Mind Medicine (MindMed) Inc. | -2.44 USD | -9525701.23% |
| Q32 Bio Inc. | -35.16 USD | -660962.429% |
| Brainstorm Cell Therapeutics Inc. | -0.40 USD | -58107287.5% |
| Alumis Inc. Common Stock | -2.99 USD | -7773463.545% |
| Equillium, Inc. | -0.38 USD | -61165571.053% |
| Kyverna Therapeutics, Inc. | -0.00 USD | -232429549900.0% |
| Coya Therapeutics, Inc. | -0.79 USD | -29421362.025% |
| CNS Pharmaceuticals, Inc. | -251.35 USD | -92372.469% |
| Galera Therapeutics, Inc. | -1.33 USD | -17475806.015% |
| Evelo Biosciences, Inc. | -26.28 USD | -884335.122% |
| Comera Life Sciences Holdings, Inc. | -1.76 USD | -13206124.432% |
| Dominari Holdings Inc. | -4.38 USD | -5306510.731% |
| Edesa Biotech, Inc. | -2.93 USD | -7932649.147% |
| vTv Therapeutics Inc. | -9.71 USD | -2393613.182% |
| Bio-Techne Corporation | 1.07 USD | 21722487.85% |
| Agios Pharmaceuticals, Inc. | -6.33 USD | -3671772.828% |
| Harmony Biosciences Holdings, Inc. | 2.17 USD | 10711139.171% |
| Prelude Therapeutics Incorporated | -2.02 USD | -11506313.366% |
| Candel Therapeutics, Inc. | -1.31 USD | -17742613.74% |
| iTeos Therapeutics, Inc. | -3.15 USD | -7378615.873% |
| Nkarta, Inc. | -2.40 USD | -9684464.583% |
| BioCardia, Inc. | -8.19 USD | -2837867.643% |
| Iterum Therapeutics plc | -2.96 USD | -7852249.662% |